Jeffrey E. Campbell

1.5k total citations
23 papers, 1.2k citations indexed

About

Jeffrey E. Campbell is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Jeffrey E. Campbell has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Organic Chemistry and 12 papers in Pharmacology. Recurrent topics in Jeffrey E. Campbell's work include Nicotinic Acetylcholine Receptors Study (17 papers), Cholinesterase and Neurodegenerative Diseases (12 papers) and Chemical synthesis and alkaloids (10 papers). Jeffrey E. Campbell is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (17 papers), Cholinesterase and Neurodegenerative Diseases (12 papers) and Chemical synthesis and alkaloids (10 papers). Jeffrey E. Campbell collaborates with scholars based in United States and United Kingdom. Jeffrey E. Campbell's co-authors include Stephen P. Arnerić, Mark W. Holladay, James P. Sullivan, Diana L. Donnelly‐Roberts, David J. Anderson, Keith B. Ryther, Marietta Piattoni-Kaplan, James T. Wasicak, Michael Decker and Nan‐Horng Lin and has published in prestigious journals such as Journal of Geophysical Research Atmospheres, Brain Research and Journal of Medicinal Chemistry.

In The Last Decade

Jeffrey E. Campbell

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey E. Campbell United States 18 805 293 224 202 200 23 1.2k
Dennis L. Larson United States 21 1.1k 1.4× 71 0.2× 1.1k 4.9× 21 0.1× 139 0.7× 71 1.7k
Masahiro Nishio Japan 14 250 0.3× 20 0.1× 100 0.4× 129 0.6× 124 0.6× 60 827
Qianqian Cao China 19 317 0.4× 101 0.3× 117 0.5× 35 0.2× 94 0.5× 66 1.0k
Hai Zhang China 24 461 0.6× 134 0.5× 329 1.5× 16 0.1× 75 0.4× 53 1.4k
Yu‐Chi Lin Taiwan 21 524 0.7× 252 0.9× 12 0.1× 140 0.7× 173 0.9× 114 1.6k
Beata Ostachowicz Poland 16 143 0.2× 133 0.5× 125 0.6× 12 0.1× 14 0.1× 46 807
Richard T. Reid United States 17 574 0.7× 224 0.8× 186 0.8× 20 0.1× 95 0.5× 26 987
Véronique André France 19 181 0.2× 55 0.2× 201 0.9× 71 0.4× 19 0.1× 40 1.1k
S. L. Hu China 13 321 0.4× 39 0.1× 126 0.6× 3 0.0× 12 0.1× 51 602

Countries citing papers authored by Jeffrey E. Campbell

Since Specialization
Citations

This map shows the geographic impact of Jeffrey E. Campbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey E. Campbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey E. Campbell more than expected).

Fields of papers citing papers by Jeffrey E. Campbell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey E. Campbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey E. Campbell. The network helps show where Jeffrey E. Campbell may publish in the future.

Co-authorship network of co-authors of Jeffrey E. Campbell

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey E. Campbell. A scholar is included among the top collaborators of Jeffrey E. Campbell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey E. Campbell. Jeffrey E. Campbell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilson, Michael W., Paul D. Johnson, Shelley R. Graham, et al.. (2009). Synthesis and SAR of tolylamine 5-HT6 antagonists. Bioorganic & Medicinal Chemistry Letters. 19(9). 2409–2412. 17 indexed citations
2.
Knauer, Christopher S., Jeffrey E. Campbell, Christopher Bowman, et al.. (2008). Validation of a rat in vivo [3H]M100907 binding assay to determine a translatable measure of 5-HT2A receptor occupancy. European Journal of Pharmacology. 591(1-3). 136–141. 23 indexed citations
3.
Knauer, Christopher S., Jeffrey E. Campbell, Christopher L. Chio, & Lawrence W. Fitzgerald. (2008). Pharmacological characterization of mitogen-activated protein kinase activation by recombinant human 5-HT2C, 5-HT2A, and 5-HT2B receptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 379(5). 461–471. 18 indexed citations
4.
Lin, Nan‐Horng, Yihong Li, Yun He, et al.. (2001). Synthesis and structure–activity relationships of 5-substituted pyridine analogues of 3-[2-((S)-pyrrolidinyl)methoxy]pyridine, A-84543. Bioorganic & Medicinal Chemistry Letters. 11(5). 631–633. 20 indexed citations
5.
Krow, Grant R., Jing Yuan, Yuhong Fang, et al.. (2000). Synthesis of 3- and 5-endo-(6-Chloro-3-pyridoxy)-methyl-2-azabicyclo[2.2.0]hexane and 3-endo-(6-Chloro-3-pyridoxy)-methyl-2-azabicyclo[2.2.0]hex-5-ene. ABT-594 Analogs. Tetrahedron. 56(47). 9227–9232. 15 indexed citations
6.
Meyer, Michael D., David J. Anderson, Jeffrey E. Campbell, et al.. (2000). Preclinical Pharmacology of ABT‐594: A Nicotinic Acetylcholine Receptor Agonist for the Treatment of Pain. CNS Drug Reviews. 6(3). 183–194. 5 indexed citations
7.
Lin, Nan‐Horng, David Gunn, Suzanne A. Lebold, et al.. (1999). Structure-activity studies on a novel series of cholinergic channel activators based on a heteroaryl ether framework. Bioorganic & Medicinal Chemistry Letters. 9(18). 2747–2752. 12 indexed citations
8.
Bannon, Anthony W., Michael Decker, David J.B. Kim, Jeffrey E. Campbell, & Stephen P. Arnerić. (1998). ABT-594, a novel cholinergic channel modulator, is efficacious in nerve ligation and diabetic neuropathy models of neuropathic pain. Brain Research. 801(1-2). 158–163. 37 indexed citations
9.
Lin, Nan‐Horng, David Gunn, Yihong Li, et al.. (1998). Synthesis and structure-activity relationships of pyridine-modified analogs of 3-[2-((S)-pyrrolidinyl)methoxy]pyridine, A-84543, a potent nicotinic acetylcholine receptor agonist. Bioorganic & Medicinal Chemistry Letters. 8(3). 249–254. 35 indexed citations
10.
Donnelly‐Roberts, Diana L., Pamela S. Puttfarcken, Theresa A. Kuntzweiler, et al.. (1998). ABT-594 [(R)-5-(2-Azetidinylmethoxy)-2-Chloropyridine]: A Novel, Orally Effective Analgesic Acting via Neuronal Nicotinic Acetylcholine Receptors: I. In Vitro Characterization. Journal of Pharmacology and Experimental Therapeutics. 285(2). 777–786. 79 indexed citations
12.
Briggs, Clark A., David J. Anderson, Jorge D. Brioni, et al.. (1997). Functional Characterization of the Novel Neuronal Nicotinic Acetylcholine Receptor Ligand GTS-21 In Vitro and In Vivo. Pharmacology Biochemistry and Behavior. 57(1-2). 231–241. 171 indexed citations
13.
Sullivan, James P., Diana L. Donnelly‐Roberts, David J. Anderson, et al.. (1997). ABT-089 [2-Methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A Potent and Selective Cholinergic Channel Modulator with Neuroprotective Properties. Journal of Pharmacology and Experimental Therapeutics. 283(1). 235–246. 70 indexed citations
14.
Arnerić, Stephen P., Jeffrey E. Campbell, Jerome F. Daanen, et al.. (1997). ABT-089 [3-(2(S)-pyrrolidinylmethoxy)-2-methyl-pyridine]: An orally effective cholinergic channel modulator with potential once-a-day dosing and cardiovascular safety. Drug Development Research. 41(1). 31–43. 7 indexed citations
15.
Donnelly‐Roberts, Diana L., David J. Anderson, Murali Gopalakrishnan, et al.. (1996). A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: In Vitro pharmacological properties of a novel, high affinity α4β2 nicotinic acetylcholine receptor ligand. Neuropharmacology. 35(6). 725–734. 121 indexed citations
16.
Jacyno, John M., John S. Harwood, Nan‐Horng Lin, et al.. (1996). Lycaconitine Revisited:  Partial Synthesis and Neuronal Nicotinic Acetylcholine Receptor Affinities. Journal of Natural Products. 59(7). 707–709. 33 indexed citations
17.
Turek, Joseph W., Chae Hee Kang, Jeffrey E. Campbell, Stephen P. Arnerić, & James P. Sullivan. (1995). A sensitive technique for the detection of the α7 neuronal nicotinic acetylcholine receptor antagonist, methyllycaconitine, in rat plasma and brain. Journal of Neuroscience Methods. 61(1-2). 113–118. 81 indexed citations
18.
Anderson, David J., M. Williams, J L Raszkiewicz, et al.. (1995). Characterization of [3H]ABT-418: a novel cholinergic channel ligand.. Journal of Pharmacology and Experimental Therapeutics. 273(3). 1434–1441. 28 indexed citations
19.
Elliott, Richard L., Keith B. Ryther, David J. Anderson, et al.. (1995). Phenyl pyrrolidine analogues as potent nicotinic acetylcholine receptor (nAChR) ligands. Bioorganic & Medicinal Chemistry Letters. 5(9). 991–996. 20 indexed citations
20.
Campbell, Jeffrey E.. (1990). Dielectric Properties and Influence of Conductivity in Soils at One to Fifty Megahertz. Soil Science Society of America Journal. 54(2). 332–341. 234 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026